2015
DOI: 10.1073/pnas.1505168112
|View full text |Cite
|
Sign up to set email alerts
|

EGFR inhibits DNA mismatch repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…The mobilization of ErbB receptor dimers and gap junctions interfere in several ways. Nuclear DNA injury releases signaling factors like HSPs and ARPs [ 28 , 57 ] which target not only Erb receptor dimers and induce caveolin and importin- dependent nucleograde transport [ 58 , 59 ], but also affect the retrograde trafficking of gap junctions [ 60 , 61 , 62 ]. This initiates transport routes which guide internalized and vesicle-packed gap junctions towards the perinuclear cytosol by utilizing structural, functional, and regulation components of the regular retrograde trafficking machinery.…”
Section: Introductionmentioning
confidence: 99%
“…The mobilization of ErbB receptor dimers and gap junctions interfere in several ways. Nuclear DNA injury releases signaling factors like HSPs and ARPs [ 28 , 57 ] which target not only Erb receptor dimers and induce caveolin and importin- dependent nucleograde transport [ 58 , 59 ], but also affect the retrograde trafficking of gap junctions [ 60 , 61 , 62 ]. This initiates transport routes which guide internalized and vesicle-packed gap junctions towards the perinuclear cytosol by utilizing structural, functional, and regulation components of the regular retrograde trafficking machinery.…”
Section: Introductionmentioning
confidence: 99%
“…Mammalian cells have evolved sophisticated DNA repair systems to correct mispaired or damaged bases and extrahelical loops. In the mismatch repair (MMR) pathway, MutS-like heterodimers (MutSα, MSH2–MSH6 and MutSβ, MSH2–MSH3) recognize chemically modified or extrahelical DNA, and initiate sequential assembly of downstream repair machinery to repair the lesion 1 2 3 . Surprisingly, however, the eukaryotic mismatch recognition complex, MSH2–MSH3, not only fails to act as a guardian of the genome at the long disease-length trinucleotide repeat (TNR) tracts but also causes expansion, the lethal mutation underlying Huntington's disease (HD) as well as at least 30 other fatal diseases 4 5 6 7 8 .…”
mentioning
confidence: 99%
“…In summary, this novel study provides evidence that PCNA-Y211p may be more abundant in EGFR-expressing cancer cells, and this may lower the efficiency of MMR, compounding other factors that deregulate genome maintenance and/or cell growth control in EGFR-positive human cancer cells. This study suggests a novel mechanism by which post-translational modification of replicative factor PCNA could lead to increased mutation rate and/or cancer progression [79, 80]. Additional in vivo and clinical studies are needed to explore the implications of this result.…”
Section: Pcna Tyrosine Phosphorylation In Cancer Cells Alters Its Funmentioning
confidence: 99%